Synchron, a company that develops a brain-computer interface to help paralyzed patients text, email, and shop online, raises $40M from Khosla Ventures (Andrea Park/FierceBiotech)

synchron 40m khosla venturesparkfiercebiotech

Synchron, which is developing a brain-computer interface that helps paralysis patients text, email, and shop online, raises $40M Series B led by Khosla Ventures (Andrea Park/FierceBiotech)

Andrea Park / FierceBiotech:

Synchron, which is developing a brain-computer interface that helps paralysis patients text, email, and shop online, raises $40M Series B led by Khosla Ventures  —  After years of focusing on all things artificial intelligence, lifefitnessguide.com the buzziest buzz in medtech now centers not on robots and algorithms …